These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23021933)

  • 21. Exploring depression in schizophrenia.
    Maggini C; Raballo A
    Eur Psychiatry; 2006 Jun; 21(4):227-32. PubMed ID: 16356690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scales for evaluating depressive symptoms in Chinese patients with schizophrenia.
    Liu H; Zhang H; Xiao W; Liu Q; Fu P; Chen J; Wang G; Yang F; Wang G; Wang X; Li L
    J Nerv Ment Dis; 2009 Feb; 197(2):140-2. PubMed ID: 19214051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).
    Müller MJ; Marx-Dannigkeit P; Schlösser R; Wetzel H; Addington D; Benkert O
    J Psychiatr Res; 1999; 33(5):433-43. PubMed ID: 10504012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability of the Calgary depression scale for schizophrenia: A meta-analysis.
    Porter L; Jones C; Fox A
    Schizophr Res; 2022 Feb; 240():32-45. PubMed ID: 34920367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
    Rekhi G; Alphs L; Ang MS; Lee J
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of four scales measuring depression in schizophrenic inpatients.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Margariti MM; Collias CT; Christodoulou GN
    Eur Psychiatry; 2000 Jun; 15(4):274-7. PubMed ID: 10951613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia.
    Lako IM; Bruggeman R; Knegtering H; Wiersma D; Schoevers RA; Slooff CJ; Taxis K
    J Affect Disord; 2012 Sep; 140(1):38-47. PubMed ID: 22099566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study on quality of life of patients of schizophrenia with and without depression.
    Dan A; Kumar S; Avasthi A; Grover S
    Psychiatry Res; 2011 Sep; 189(2):185-9. PubMed ID: 21453977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of Turkish version of brief negative symptom scale.
    Polat Nazlı I; Ergül C; Aydemir Ö; Chandhoke S; Üçok A; Gönül AS
    Int J Psychiatry Clin Pract; 2016 Nov; 20(4):265-71. PubMed ID: 27409157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between psychopathology and suicidal behavior in schizophrenia. A cross-sectional study of 509 participants.
    Jovanović N; Podlesek A; Medved V; Grubišin J; Mihaljevic-Peleš A; Goran T; Lovretić V
    Crisis; 2013 Jan; 34(6):374-81. PubMed ID: 23942386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
    Peralta V; Cuesta MJ
    Psychiatry Res; 1994 Jul; 53(1):31-40. PubMed ID: 7991730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Validation of the French version of the self-evaluation of negative symptoms (SNS)].
    Hervochon C; Bourgeois V; Rotharmel M; Duboc JB; Le Goff B; Quesada P; Campion D; Dollfus S; Guillin O
    Encephale; 2018 Dec; 44(6):512-516. PubMed ID: 29195803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor analysis of symptom dimensions (psychotic, affective and obsessive compulsive symptoms) in schizophrenia.
    Grover S; Dua D; Chakrabarti S; Avasthi A
    Asian J Psychiatr; 2018 Dec; 38():72-77. PubMed ID: 29108803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and optimal cut-off score of the World Health Organization Well-being Index (WHO-5) as a screening tool for depression among patients with schizophrenia.
    Fekih-Romdhane F; Al Mouzakzak F; Abilmona G; Dahdouh O; Hallit S
    BMC Psychiatry; 2024 May; 24(1):391. PubMed ID: 38783217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.